Cargando…

Effects of a newly developed potent orexin-2 receptor-selective antagonist, compound 1 m, on sleep/wakefulness states in mice

Orexins (also known as hypocretins) play critical roles in the regulation of sleep/wakefulness states by activating two G-protein coupled receptors (GPCRs), orexin 1 (OX(1)R) and orexin 2 receptors (OX(2)R). In order to understand the differential contribution of both receptors in regulating sleep/w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Etori, Keishi, Saito, Yuki C., Tsujino, Natsuko, Sakurai, Takeshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2014
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3907770/ https://www.ncbi.nlm.nih.gov/pubmed/24550770 http://dx.doi.org/10.3389/fnins.2014.00008

Ejemplares similares

Differential Roles of Orexin Receptors in the Regulation of Sleep/Wakefulness
por: Mieda, Michihiro, et al.
Publicado: (2013)

Serotonergic Input to Orexin Neurons Plays a Role in Maintaining Wakefulness and REM Sleep Architecture
por: Saito, Yuki C., et al.
Publicado: (2018)

Pharmacogenetic Modulation of Orexin Neurons Alters Sleep/Wakefulness States in Mice
por: Sasaki, Koh, et al.
Publicado: (2011)

Hypocretin (orexin) regulation of sleep-to-wake transitions
por: de Lecea, Luis, et al.
Publicado: (2014)

Neurotensin Co-Expressed in Orexin-Producing Neurons in the Lateral Hypothalamus Plays an Important Role in Regulation of Sleep/Wakefulness States
por: Furutani, Naoki, et al.
Publicado: (2013)

Role of orexin in modulating arousal, feeding, and motivation
por: Tsujino, Natsuko, et al.
Publicado: (2013)

Orexin, orexin receptor antagonists and central cardiovascular control
por: Carrive, Pascal
Publicado: (2013)

Editorial: The Role of Neuropeptides in Sleep/Wakefulness States and the Circadian Clock
por: Tsujino, Natsuko, et al.
Publicado: (2022)

The hypocretin/orexin antagonist almorexant promotes sleep without impairment of performance in rats
por: Morairty, Stephen R., et al.
Publicado: (2014)

GABAergic neurons in the preoptic area send direct inhibitory projections to orexin neurons
por: Saito, Yuki C., et al.
Publicado: (2013)

LSN2424100: a novel, potent orexin-2 receptor antagonist with selectivity over orexin-1 receptors and activity in an animal model predictive of antidepressant-like efficacy
por: Fitch, Thomas E., et al.
Publicado: (2014)

Opportunities and perspectives for developing orexin receptor antagonists
por: Steiner, Michel A., et al.
Publicado: (2014)

Orexin receptor antagonists as therapeutic agents for insomnia
por: Equihua, Ana C., et al.
Publicado: (2013)

Orexin antagonists for neuropsychiatric disease: progress and potential pitfalls
por: Yeoh, Jiann Wei, et al.
Publicado: (2014)

Kinetic properties of “dual” orexin receptor antagonists at OX(1)R and OX(2)R orexin receptors
por: Callander, Gabrielle E., et al.
Publicado: (2013)

Orexin-1 and orexin-2 receptor antagonists reduce ethanol self-administration in high-drinking rodent models
por: Anderson, Rachel I., et al.
Publicado: (2014)

THE REGULATION OF SLEEP AND WAKEFULNESS BY THE HYPOTHALAMIC NEUROPEPTIDE OREXIN/HYPOCRETIN
por: INUTSUKA, AYUMU, et al.
Publicado: (2013)

AM-251, A Cannabinoid Antagonist, Modifies the Dynamics of Sleep–Wake Cycles in Rats
por: Bogáthy, Emese, et al.
Publicado: (2019)

Orexin-1 receptor blockade dysregulates REM sleep in the presence of orexin-2 receptor antagonism
por: Dugovic, Christine, et al.
Publicado: (2014)

OX(1) and OX(2) orexin/hypocretin receptor pharmacogenetics
por: Thompson, Miles D., et al.
Publicado: (2014)

Orexin 1 receptor antagonists in compulsive behavior and anxiety: possible therapeutic use
por: Merlo Pich, Emilio, et al.
Publicado: (2014)

Orexin receptor antagonist-induced sleep does not impair the ability to wake in response to emotionally salient acoustic stimuli in dogs
por: Tannenbaum, Pamela L., et al.
Publicado: (2014)

Preclinical in vivo characterization of lemborexant (E2006), a novel dual orexin receptor antagonist for sleep/wake regulation
por: Beuckmann, Carsten Theodor, et al.
Publicado: (2019)

Pharmacological characterization of a novel potent, selective, and orally active orexin 2 receptor antagonist, SDM‐878
por: Maehara, Shunsuke, et al.
Publicado: (2020)

Different doses of dual orexin receptor antagonists in primary insomnia: a Bayesian network analysis
por: Xue, Tao, et al.
Publicado: (2023)

Modulation of sleep behavior in zebrafish larvae by pharmacological targeting of the orexin receptor
por: Pardon, Marie, et al.
Publicado: (2022)

Chronic Alterations in Monoaminergic Cells in the Locus Coeruleus in Orexin Neuron-Ablated Narcoleptic Mice
por: Tsujino, Natsuko, et al.
Publicado: (2013)

Dual orexin receptor antagonists show distinct effects on locomotor performance, ethanol interaction and sleep architecture relative to gamma-aminobutyric acid-A receptor modulators
por: Ramirez, Andres D., et al.
Publicado: (2013)

Hypocretin/Orexin Neuropeptides: Participation in the Control of Sleep-Wakefulness Cycle and Energy Homeostasis
por: Nuñez, A, et al.
Publicado: (2009)

The physiological role of orexin/hypocretin neurons in the regulation of sleep/wakefulness and neuroendocrine functions
por: Inutsuka, Ayumu, et al.
Publicado: (2013)

Neurons containing orexin or melanin concentrating hormone reciprocally regulate wake and sleep
por: Konadhode, Roda Rani, et al.
Publicado: (2015)

Effects of the selective orexin-2 receptor antagonist JNJ-48816274 on sleep initiated in the circadian wake maintenance zone: a randomised trial
por: Revell, Victoria L., et al.
Publicado: (2021)

Orexin Receptor Blockade-Induced Sleep Preserves the Ability to Wake in the Presence of Threat in Mice
por: Iwakawa, Shouhei, et al.
Publicado: (2019)

Revisiting Preclinical Observations of Several Histamine H3 Receptor Antagonists/Inverse Agonists in Cognitive Impairment, Anxiety, Depression, and Sleep–Wake Cycle Disorder
por: Alhusaini, Mera, et al.
Publicado: (2022)

Orexin A and orexin receptor 1 axonal traffic in dorsal roots at the CNS/PNS interface
por: Colas, Damien, et al.
Publicado: (2014)

The selective orexin receptor 1 antagonist ACT-335827 in a rat model of diet-induced obesity associated with metabolic syndrome
por: Steiner, Michel A., et al.
Publicado: (2013)

Suvorexant, an FDA-approved dual orexin receptor antagonist, reduces oxycodone self-administration and conditioned reinstatement in male and female rats
por: Illenberger, Jessica M., et al.
Publicado: (2023)

Orexin, cardio-respiratory function, and hypertension
por: Li, Aihua, et al.
Publicado: (2014)

Evaluation of JNJ-54717793 a Novel Brain Penetrant Selective Orexin 1 Receptor Antagonist in Two Rat Models of Panic Attack Provocation
por: Bonaventure, Pascal, et al.
Publicado: (2017)

The evolutionarily conserved miRNA-137 targets the neuropeptide hypocretin/orexin and modulates the wake to sleep ratio
por: Holm, Anja, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_b4o2g2ffog00vvjlecic2nc73t